首页> 外文期刊>Canadian Urological Association Journal >Management of recurrent post-prostatectomy incontinence after previous failed retrourethral male slings
【24h】

Management of recurrent post-prostatectomy incontinence after previous failed retrourethral male slings

机译:先前失败的男性后尿道吊带术后复发性前列腺切除术后尿失禁的管理

获取原文
           

摘要

Objective: Our objective was to establish the feasibility of combining 2 minimally invasive procedures in patients with failed primary treatment (male sling) in post-prostatectomy incontinence (PPI) patients. Methods: From January 2007 to July 2008, 40 men with PPI were implanted with a suburethral tape (2 patients with Seratim, 3 with I-Stop and 35 with Advance). The median preoperative pad count was 4 (range 2–10). Prior to sling placement, 6 patients had undergone ProACT implantation. Of these, 4 patients required explantation due to balloon migration and 2 patients had their balloons kept in situ, with the balloons deflated. Results: Twenty-five patients were socially continent at this time. Fifteen patients (37.5%) did not improve or their improvement was not significant. These patients had a preoperative pad count between 7 and 10. Two of these patients had prostate adjustable continence therapy (ProACT) systems still in place. By gradually filling the balloons to 3 mL, both of these patients achieved complete continence, which was maintained at a mean follow-up of 8.5 months. Three patients with prior pelvic irradiation received an artificial urinary sphincter and achieved continence at mean follow-up of 8.3 months. The remaining 10 patients received a ProACT system in addition to the already implanted sling. After appropriate healing and filling of the balloons (average balloon volume 5 mL), all 10 patients reached complete continence; they were pad-free at a mean follow-up of 6 months (range 3–9). Conclusions: The combination of ProACT and a suburethral tape was demonstrated to be a possible treatment option in recurrent or persistent PPI.
机译:目的:我们的目的是确定在前列腺切除术后尿失禁(PPI)患者中,采用两种微创治疗方法合并主要治疗失败(男性吊带)的患者的可行性。方法:自2007年1月至2008年7月,为40例PPI男性植入尿道下带(2例Seratim,3例I-Stop和35例Advance)。术前平均垫数为4(范围2-10)。在放置吊索之前,有6位患者接受了ProACT植入。其中,有4位患者由于球囊迁移而需要移植,还有2位患者将球囊保留在原位,并向球囊放气。结果:此时有25名患者处于社交大陆。 15名患者(37.5%)没有改善或改善不明显。这些患者的术前垫数在7到10之间。其中两个患者仍在使用前列腺可调式自控疗法(ProACT)系统。通过逐渐将球囊填充至3 mL,这两名患者均实现了完全节制,平均随访时间为8.5个月。三名接受过骨盆放疗的患者接受了人工尿道括约肌治疗,并在平均8.3个月的随访中实现了节制。除已植入的吊带外,其余10名患者还接受了ProACT系统。经过适当的愈合和球囊充盈(平均球囊体积为5 mL)后,所有10例患者均达到完全节制。他们无垫,平均随访6个月(范围3–9)。结论:ProACT和尿道下带的组合被证明是复发性或持续性PPI的可能治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号